Opportunity ID: 333645

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH21-2173
Funding Opportunity Title: Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 18, 2021
Last Updated Date: May 18, 2021
Original Closing Date for Applications: Jul 17, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Jul 20, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 19, 2021
Estimated Total Program Funding: $205,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: The only eligible applicant to apply for this NOFO is All India Institute of Medical Sciences. The applicant must comply with Government of India Health Ministry’s Screening Committee (HMSC) clearance requirements if required and adhere to Government of India rules and regulations for foreign funding.

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: Antimicrobial resistance (AMR) is a global patient safety and public health concern.   Hospital acquired infections (HAI) lead to adverse outcomes and increased cost of treatment.   Effective infection prevention and control (IPC) interventions can reduce HAIs. The Government of India has prioritized combating AMR.   The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states.  Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data.   In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.
The Government of India has prioritized combating AMR.   The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. 
Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data.   In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities.
Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs.
The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Laura Shelby
lks2@cdc.gov
Email:lks2@cdc.gov

Version History

Version Modification Description Updated Date
Due date amended to July 20, 2021. May 18, 2021
May 18, 2021

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH21-2173
Funding Opportunity Title: Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 18, 2021
Last Updated Date: May 18, 2021
Original Closing Date for Applications: Jul 17, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Jul 20, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 19, 2021
Estimated Total Program Funding: $205,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: The only eligible applicant to apply for this NOFO is All India Institute of Medical Sciences. The applicant must comply with Government of India Health Ministry’s Screening Committee (HMSC) clearance requirements if required and adhere to Government of India rules and regulations for foreign funding.

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: Antimicrobial resistance (AMR) is a global patient safety and public health concern.   Hospital acquired infections (HAI) lead to adverse outcomes and increased cost of treatment.   Effective infection prevention and control (IPC) interventions can reduce HAIs. The Government of India has prioritized combating AMR.   The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states.  Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data.   In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.
The Government of India has prioritized combating AMR.   The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. 
Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data.   In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities.
Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs.
The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Laura Shelby
lks2@cdc.gov
Email:lks2@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH21-2173
Funding Opportunity Title: Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 18, 2021
Last Updated Date: May 18, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Jul 17, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 19, 2021
Estimated Total Program Funding: $205,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: The only eligible applicant to apply for this NOFO is All India Institute of Medical Sciences. The applicant must comply with Government of India Health Ministry’s Screening Committee (HMSC) clearance requirements if required and adhere to Government of India rules and regulations for foreign funding.

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: Antimicrobial resistance (AMR) is a global patient safety and public health concern.   Hospital acquired infections (HAI) lead to adverse outcomes and increased cost of treatment.   Effective infection prevention and control (IPC) interventions can reduce HAIs. The Government of India has prioritized combating AMR.   The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states.  Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data.   In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.
The Government of India has prioritized combating AMR.   The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. 
Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data.   In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities.
Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs.
The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Laura Shelby
lks2@cdc.gov
Email:lks2@cdc.gov

Folder 333645 Full Announcement-Full Announcement -> CDC-RFA-GH21-2173 rev.pdf

Packages

Agency Contact Information: Laura Shelby
lks2@cdc.gov
Email: lks2@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.318 CDC-RFA-GH21-2173 Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India PKG00267213 May 18, 2021 Jul 20, 2021 View

Package 1

Mandatory forms

333645 SF424_3_0-3.0.pdf

333645 Project_AbstractSummary_2_0-2.0.pdf

333645 SFLLL_2_0-2.0.pdf

333645 SF424A-1.0.pdf

333645 ProjectNarrativeAttachments_1_2-1.2.pdf

333645 BudgetNarrativeAttachments_1_2-1.2.pdf

Optional forms

333645 OtherNarrativeAttachments_1_2-1.2.pdf

2025-07-11T09:07:55-05:00

Share This Post, Choose Your Platform!

About the Author: